Patents by Inventor Michael Michaud

Michael Michaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969576
    Abstract: Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid single CGM readings.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: April 30, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Michaud, Garrett Marin, Geoffrey A. Kruse, Jacob Kearns, Thomas R. Ulrich, Trevor Denbo, David Berger
  • Publication number: 20240127923
    Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 18, 2024
    Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
  • Publication number: 20240123140
    Abstract: Methods and systems are disclosed wherein temperature in a device such as an ambulatory infusion pump is monitored during inductive charging of the device such that temperature-sensitive contents or components, such as, for example, insulin, particular circuitry and/or other components are not damaged. Temperature can be monitored in the device at one or more locations during inductive charging. If the temperature breaches one or more predetermined thresholds and/or is rising at a rate greater than one or more predetermined thresholds, charging can be suspended or provided at reduced power to prevent the temperature from further rising and damaging the contents and/or components of the device. One or more alerts associated with these events may also be triggered so that the user is aware of the situation and may take corrective action.
    Type: Application
    Filed: December 22, 2023
    Publication date: April 18, 2024
    Inventors: Caleb Butler, Robert Eastridge, Michael Michaud, Philip S. Lamb, Geoffrey A. Kruse
  • Patent number: 11951284
    Abstract: Apparatuses and methods for transitioning to sleep mode or otherwise modified glucose target range in automated insulin delivery systems. For example, sleep mode can include a lower glucose target and/or lower and narrower glucose target range because of fewer variables that affect glucose values during sleep such as eating and exercise. Due to increased stability provided by the sleep mode target range, it is desirable to transition to the sleep mode target range as quickly as possible, while ensuring the transition is done safely and does not risk low glucose or hypoglycemia by too quickly switching to the lower and narrower target range. Systems and methods disclosed herein therefore provide various approaches for safely and quickly transitioning to sleep mode or other modified target ranges in order to improve time in range by being more aggressive to get to the lower sleep mode or other target faster without risking hypoglycemia.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: April 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Alexandra Elena Constantin, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Virginia S. Lu, Garrett Marin
  • Patent number: 11941978
    Abstract: Traffic signal timing plans are derived from vehicle trajectory or probe data. The probe data is collected and archived in a datastore over a sample time on the order of weeks or longer. Probe data is corrected for clock drift, geo-fence filtered to a selected intersection, and then stop line crossings in the intersection are identified and analyzed along with related data to determine the timing plans and schedule for the intersection. In this way, access to government agency timing plans is obviated so as to save time and expense.
    Type: Grant
    Filed: September 17, 2022
    Date of Patent: March 26, 2024
    Assignee: TRAFFIC TECHNOLOGY SERVICES, INC.
    Inventors: Justin Michael Neill, Brandon Keith Sams, Jonah Aaron Pincetich, Darryl Joseph Michaud, Thomas Bauer, Jingtao Ma
  • Publication number: 20240084959
    Abstract: A bipod support for a drain cleaning machine is described. The bipod support includes a base, a plurality of legs, a retaining member, and a latch. The retaining member and latch are configured to engage and secure the drain cleaning machine to the bipod support. The bipod support enables rocking movement of the drain cleaning machine while supporting the weight of the machine. Also described are related methods of use of the bipod support.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 14, 2024
    Inventors: Emily Jo SPINELLI, Kaylin JACOBSEN, Sarah MICHAUD, Jeffrey SZUCS, Alex M. COLE, Michael J. RUTKOWSKI, Nicholas Christopher MAVROS, Jacob SCHNEIDER
  • Patent number: 11872368
    Abstract: Methods and systems are disclosed wherein temperature in a device such as an ambulatory infusion pump is monitored during inductive charging of the device such that temperature-sensitive contents or components, such as, for example, insulin, particular circuitry and/or other components are not damaged. Temperature can be monitored in the device at one or more locations during inductive charging. If the temperature breaches one or more predetermined thresholds and/or is rising at a rate greater than one or more predetermined thresholds, charging can be suspended or provided at reduced power to prevent the temperature from further rising and damaging the contents and/or components of the device. One or more alerts associated with these events may also be triggered so that the user is aware of the situation and may take corrective action.
    Type: Grant
    Filed: April 10, 2019
    Date of Patent: January 16, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Caleb Butler, Robert Eastridge, Michael Michaud, Philip S. Lamb, Geoffrey A. Kruse
  • Patent number: 11869650
    Abstract: Disclosed herein are systems and methods for remotely monitoring and/or controlling medical therapy of a patient. Embodiments of the current disclosure provide a remote monitoring and/or control architecture that can establish a predetermined set of permissions for real time monitoring of patient data and/or notifications and/or control of medical device therapy. The system can include permissions to determine who, how and when information and/or control is shared that can consider factors such as time, location and relationship with the patient.
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: January 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Manuel Jaime, Josh Juster, Larkin Lowrey, Geoffrey A. Kruse, Garrett Marin, Michael Michaud
  • Publication number: 20230381406
    Abstract: Embodiments of the present disclosure relate to use of a filter in an infusion pump system. The filter can be comprised of a rigid porous plastic material that provides a three-dimensional tortuous path of small pore size that captures particulate as it flows through the filter. Filtration efficiency can be balanced with flow restriction dependent upon pore size of the filter. A range of pore sizes is achievable.
    Type: Application
    Filed: May 24, 2023
    Publication date: November 30, 2023
    Inventors: Adam Evard, Michael Michaud
  • Publication number: 20230173170
    Abstract: Embodiments of the present disclosure relate to a holder or carrier for a user-wearable infusion pump that can be worn on or near the patient's body. Embodiments depicted and described herein provide a more versatile and secure way to hold and carry a user-wearable infusion pump.
    Type: Application
    Filed: December 5, 2022
    Publication date: June 8, 2023
    Inventors: Steven B. Cook, Philip Sven Lamb, Ryan William Betts, Michael Michaud, Virginia Lu, Neel Shah, Jacob Pearlman
  • Patent number: 11654236
    Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: May 23, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
  • Publication number: 20230113755
    Abstract: Disclosed herein are apparatuses and methods that can provide a delayed bolus calculator for use in closed loop diabetes therapy that can account for additional factors not taken into account in regular meal bolus calculations when a user wants to deliver a meal bolus a period of time after a meal was consumed. A delayed bolus calculator can enable the user to enter a period of time since the meal was consumed in addition to the number of carbohydrates consumed in a meal. This enables the system to account for the amount of increased insulin from the closed loop algorithm in response to the meal and/or the time since the meal to ensure that the risk of hypoglycemia is mitigated while still reducing hyperglycemia.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 13, 2023
    Inventors: Virginia S. Lu, Nicholas Sherer, Thomas R, Ulrich, Katherine Vyvy Tran, Jose Ricardo Rueda, Pat Mulvihill, Peter Zhao, Micah Stephens, Ryan Cardenas, Paul Harris, Geoffrey A. Kruse, Michael Michaud, Marissa Igartua
  • Publication number: 20230047034
    Abstract: Disclosed herein are apparatuses and methods for a user-wearable infusion pump actuated with a shape memory alloy (SMA) wire. Embodiments enable an SMA wire driven infusion pump using a single length of SMA wire to provide multiple pulse sizes and corresponding medicament dispensing sizes. The multiple pulse sizes can include a larger pulse size for larger volumes to limit battery drain but smaller pulse sizes for precision of delivery.
    Type: Application
    Filed: August 12, 2022
    Publication date: February 16, 2023
    Inventor: Michael Michaud
  • Publication number: 20230040677
    Abstract: An alternate mode for addressing meals in closed loop insulin delivery systems is disclosed. An Eating Soon Mode may be a user-selectable feature that can be activated when a user anticipates eating a meal in the near future. Once activated, Eating Soon Mode preemptively modifies the closed loop algorithm in preparation for the expected rise in glucose levels from consumption of the meal. This can result in a greater amount of time in range for the user, a lower coefficient of variation of the user's glucose levels and/or a lower maximum BG level for the user. According to embodiments disclosed herein, activation of Eating Soon Mode modifies the algorithm to deliver a correction bolus to lower the user's glucose level and to provide a modified, lower target range at which to maintain the user's glucose levels in anticipation of the glucose rise that will result from the meal.
    Type: Application
    Filed: August 3, 2022
    Publication date: February 9, 2023
    Inventors: Katherine Vyvy Tran, Jose Ricardo Rueda, Nicholas Sherer, Thomas R. Ulrich, Pat Mulvihill, Peter Zhao, Micah Stephens, Ryan Cardenas, Paul Harris, Geoffrey A. Kruse, Michael Michaud, Vance Swanson, Virginia S. Lu
  • Publication number: 20230037465
    Abstract: Disclosed herein are systems and methods for automated insulin delivery that provide an Alternate Normal Activity Mode that has a lower and narrower target range than the standard range employed in Normal Mode. The Alternative Normal Mode can be a user-selectable feature that provides more aggressive glucose level control that is designed to decrease hyperglycemia without significantly increasing the risk of hypoglycemia. For example, Normal Mode may employ a standard glucose range between which the closed loop algorithm attempts to maintain the user's glucose levels such as 112.5 mg/dL to 160 mg/dL and Alternative Normal Mode may employ a lower and narrower range such as 90 mg/dL to 130 mg/dL. Alternative Normal Mode can also employ a lockout feature that is activated when glucose is high, but is falling rapidly.
    Type: Application
    Filed: April 28, 2022
    Publication date: February 9, 2023
    Inventors: Jose Ricardo Rueda, Nicholas Sherer, Thomas R. Ulrich, Katherine Vyvy Tran, Pat Mulvihill, Peter Zhao, Micah Stephens, Ryan Cardenas, Paul Harris, Geoffrey A. Kruse, Michael Michaud, Virginia S. Lu
  • Publication number: 20230030641
    Abstract: Disclosed herein are systems and methods for monitoring performance of an ambulatory infusion pump. An ambulatory infusion pump can include a reservoir configured to contain a medicament including a plunger at a proximal end of the reservoir and an outlet port at a distal end of the reservoir. A motor can be configured to cause linear motion of a pushrod to contact and move the plunger to cause medicament to flow from the reservoir out of the outlet port to a patient. An optical encoder can be employed to monitor a linear position of the pushrod. In addition, the optical encoder can be employed to monitor additional system conditions and/or a secondary encoder can be employed to monitor the performance of the optical encoder.
    Type: Application
    Filed: September 21, 2022
    Publication date: February 2, 2023
    Inventors: Alexander Seitz, Michael Michaud, Philip Sven Lamb, Justin Brown, Geoffrey A. Kruse
  • Publication number: 20230033867
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to be paired with a remote control device that can include a remote consumer electronic device such as a smartphone and/or a dedicated remote controller.
    Type: Application
    Filed: October 10, 2022
    Publication date: February 2, 2023
    Inventors: Jason Farnan, Zion Greenlee, Geoffrey A. Kruse, Michael Michaud
  • Publication number: 20230034283
    Abstract: Disclosed herein are apparatuses and methods for improved use of infusion sites for infusion pumps. Apparatuses and methods for delivery of medicaments such as insulin disclosed herein can increase the effectiveness of therapy by more accurately determining when an infusion site is no longer absorbing insulin at an acceptable rate as well as determining the effectiveness of different infusion sites on the body with respect to each other and over time.
    Type: Application
    Filed: October 10, 2022
    Publication date: February 2, 2023
    Inventors: Michael Michaud, Geoffrey A. Kruse
  • Patent number: 11464908
    Abstract: Disclosed herein are apparatuses and methods for improved use of infusion sites for infusion pumps. Apparatuses and methods for delivery of medicaments such as insulin disclosed herein can increase the effectiveness of therapy by more accurately determining when an infusion site is no longer absorbing insulin at an acceptable rate as well as determining the effectiveness of different infusion sites on the body with respect to each other and over time.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: October 11, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Michaud, Geoffrey A. Kruse
  • Patent number: D1010816
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: January 9, 2024
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Steven B. Cook, Philip Sven Lamb, Ryan William Betts, Michael Michaud